IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q4 2019 Holdings

Filed 2020-02-14 | 8 holdings | $43.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axogen Inc(AXGN)COM05463X106$43.5M2,429,99999.6%
Eyepoint Pharmaceuticals IncCOM30233G100$65.0K41,909,2190.1%
Revance Therapeutics Inc(RVNCEUR)COM761330109$54.2K3,342,0470.1%
Venus Concept IncCOM92332W105$33.0K7,017,8560.1%
Tela BIO Inc(TELA)COM872381108$10.0K769,2310.0%
Medicinova Inc(MNOV)COM NEW58468P206$7.5K1,117,3550.0%
Endologix Inc(ELGXEUR)COM NEW29266S304$717125,7470.0%
Catalyst Biosciences IncCOM NEW14888D208$53578,6220.0%